Molecular Predictors of EGFR-TKI Sensitivity in Advanced Non–small Cell Lung Cancer
<p>The epidermal growth factor receptor (EGFR) is overexpressed in the majority of non-small cell lung cancers (NSCLC) and is a major target for new therapies. Specific EGFR tyrosine kinase inhibitors (TKIs) have been developed and used for the treatment of advanced NSCLC. The clinical respons...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ivyspring International Publisher
2008-01-01
|
| Series: | International Journal of Medical Sciences |
| Online Access: | http://www.medsci.org/v05p0209.htm |